Inventor · disambiguated record
Gisela Schimmack
Also filed as: SCHIMMACK GISELA
11 granted patents·5 pending applications·10 citations·filing 2019–2025
86Inventor score
Files withIMMATICS BIOTECHNOLOGIES GMBH16
Top patents by PatentIndex Score
16 records- 0198US11732021B2Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Aug 22, 2023·3 cites·20 claims
- 0298US11655281B2Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted May 23, 2023·3 cites·20 claims
- 0398US11655280B2Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted May 23, 2023·2 cites·20 claims
- 0498US11603397B2Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Mar 14, 2023·2 cites·20 claims
- 0588US2024083969A1Immunotherapy with b*07 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 0688US2023331807A1Immunotherapy with b*07 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2023·Application pending·0 cites
- 0785US12202878B2Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Jan 21, 2025·0 cites·20 claims
- 0885US12195516B2Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2022·Granted Jan 14, 2025·0 cites·20 claims
- 0982US12084486B2Immunotherapy with B*07 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Sep 10, 2024·0 cites·20 claims
- 1079US12227556B2Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Feb 18, 2025·0 cites·17 claims
- 1178US11433099B2Immunotherapy with B*08 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2021·Granted Sep 6, 2022·0 cites·27 claims
- 1277US2020040057A1Immunotherapy with b*07 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Application pending·0 cites
- 1375US11779605B2Immunotherapy with b*08 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2019·Granted Oct 10, 2023·0 cites·11 claims
- 1475US2025019406A1Sorting with counter selection using sequence similar peptidesIMMATICS BIOTECHNOLOGIES GMBH·Filed 2024·Application pending·0 cites
- 1573US2025145684A1Immunotherapy with b*08 restricted peptides and combination of peptides against cancers and related methodsIMMATICS BIOTECHNOLOGIES GMBH·Filed 2025·Application pending·0 cites
- 1652US12480958B2Method for the characterization of peptide:MHC binding polypeptidesIMMATICS BIOTECHNOLOGIES GMBH·Filed 2020·Granted Nov 25, 2025·0 cites·22 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →